Developer docs
API playgroundTry for free, no card

Search company profiles

wavepaths

Full company profile

uuid0003c6r

Namestring
wavepaths
Legal namestring
Wavepaths
Websiteurl
wavepaths.com
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Wavepaths is a London-headquartered, fully remote company that develops an AI-driven adaptive music generation platform designed to support therapist-led experiences across psychedelic therapy, ketamine infusion therapy, breathwork, and general psychotherapy. The platform generates personalised, real-time music by weaving together exclusive contributions from over 30 collaborating artists (including Jon Hopkins, Brian Eno, and Robert Rich), with in-session adaptation tuned to the individual, the therapeutic context, and the medicine being used. The company was founded in 2019 by Dr. Mendel Kaelen, a neuroscientist whose PhD research at Imperial College London first demonstrated music's central role in psychedelic therapy outcomes, and co-founder Anna Rickman.

The product surface comprises specialised offerings for each therapeutic modality — Music for Psychedelic Therapy, Music for Ketamine Infusion Therapy (covering both KAP and KIT), Music for Breathwork, and Music for Psychotherapy — plus a research tier supporting clinical trials at Imperial College London, McGill University, University of Washington, and Monash University. Supporting services include the Foundations of Therapeutic Music training course (€350 self-paced / €1,300 live), 1:1 and group consulting with Dr. Kaelen, and Deep Listening sessions facilitated over Zoom.

Wavepaths operates a primarily subscription-based revenue model (monthly practitioner access with 14-day free trials and category-specific discounts), complemented by fee-based training, consulting, and facilitated listening services. GTM is community-led and self-serve, amplified by free webinars, founder-led AMAs, and academic research partnerships. The platform is used by 5,000+ practitioners across 29 countries and has supported 50,000+ clinical sessions; the company raised $4.5M in seed funding in November 2021 from a consortium of psychedelic- and science-focused investors.

Short descriptiontext

Wavepaths is a London-based, fully remote company that develops an AI-driven adaptive music platform for psychedelic therapy, ketamine treatment, breathwork, and psychotherapy, serving 5,000+ practitioners across 29 countries and supporting 50,000+ clinical sessions.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
adaptive therapeutic music, psychedelic therapy platform, ketamine infusion music, breathwork music software, music-assisted psychotherapy
Industry2 codes
PRIMARYMPAIAIAC
Mobile Music Creation Apps (Beatmaking, Songwriting, Practice)
Media, Entertainment & Sports/Music & Audio (Recording, Publishing, Streaming)/Music Technology & Software (DAWs, Plugins, Music Apps)
SECONDARYHSADAJAD
Sound Meditation & Sound Bath Sessions
NAICS code2 codes
  • Other Sound Recording Industries512290
  • Sound Recording Industries5122
SIC code1 code
  • Services-Computer Programming, Data Processing, Etc.7370
Product category
Therapeutic Music Software
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Subscription Platform Access
TypeSubscription Recurring
Description

Monthly subscription model for care providers to access the Wavepaths music platform for therapeutic sessions. Includes free trial periods and discounts for certain practitioner categories.

wavepaths.com
2Music Licensing for Breathwork
TypeSubscription Recurring
Description

$25 per month licensing fee during beta phase for breathwork practitioners to use adaptive music.

wavepaths.com
3Educational Training Programs
TypeProfessional Services
Description

Fee-based training courses including the Foundations of Therapeutic Music program (€350 for self-paced, €1,300 for live interactive), and 1:1/group consulting sessions with founder Mendel Kaelen.

wavepaths.com
4Deep Listening Sessions
TypeProfessional Services
Description

Paid deep listening sessions facilitated over Zoom, offered individually or for groups, lasting 1-3 hours.

wavepaths.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
Pricing details4 tiers
1Breathwork music licensing - beta pricing
ModelSubscriptionBilling cadenceMonthly
Notes

$25 per month during beta phase. Includes real-time adaptability, exclusive composed music, and remote session features.

wavepaths.com
2Foundations of Therapeutic Music - Essentials (Self-Paced)
ModelSubscriptionBilling cadencePay-as-you-go
Notes

€350 - Independent, on-demand access. Includes 20+ hours of video lectures, 10+ hours of guided practice, 9 learning modules, music recommendations, downloadable resources, completion certificate, and 3-month Wavepaths subscription.

wavepaths.com
3Foundations of Therapeutic Music - Expert (Live Interactive)
ModelSubscriptionBilling cadencePay-as-you-go
Notes

€1,300 - Live, interactive guided program. Includes all Essentials features plus 1-month playlist design workshop, interactive experientials every two weeks, guided listenings every week, live sessions & Q&A, and extended Wavepaths subscription.

wavepaths.com
4Platform Free Trial
ModelFreemiumBilling cadencePay-as-you-go
Notes

14-day free trial available. 75% off Advanced and Pro plans with code BREATHWORK75 for breathwork practitioners.

wavepaths.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Wavepaths provides an AI-driven, person-centred adaptive music platform used by therapists, ketamine clinics, breathwork facilitators, and researchers during therapeutic sessions. The platform weaves exclusive musical contributions from over 30 world-renowned artists together in real time, adapting to the individual patient, the therapeutic context, and the medicine involved. Supporting offerings include an educational Foundations of Therapeutic Music training course, 1:1/group consulting, and facilitated Deep Listening sessions.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • All three positive therapeutic outcomes (mystical experience, autobiographical insight, depression reduction) were more likely when patients responded positively to music in psychedelic therapy studies
+1 more record
Product overview1 text field

Wavepaths is a music-as-medicine platform offering adaptive, person-centred therapeutic music solutions. The core platform includes multiple specialized applications: Music for Psychedelic Therapy, Music for Ketamine Infusion Therapy, Music for Breathwork, and Music for Psychotherapy. Supporting offerings include Deep Listening sessions (guided introspective music experiences), research support for clinical trials, and subscription access for care providers. Wavepaths' technology weaves musical contributions from over 30 collaborating artists together in real-time, adapting to each individual and therapeutic context. The platform is complemented by educational programs including a Foundations of Therapeutic Music training course and 1:1 consulting services. The company serves practitioners across 29 countries and supports over 50,000 clinical sessions.

Product and service8 records
1Music for Psychedelic Therapy
CategoryTherapeutic Music Software
Description

Adaptive, person-centred music platform designed to optimize therapeutic outcomes during psychedelic-assisted therapy sessions (psilocybin, MDMA, DMT) by customising music to the pharmacodynamics of the medicine and individual patient traits. Targeted at therapists, guides, and clinicians.

2Music for Ketamine Infusion Therapy
CategoryTherapeutic Music Software
Description

Therapeutic music solution for ketamine-assisted psychotherapy (KAP) and ketamine IV therapy (KIT) practitioners, supporting both infusion-only practices and psychotherapy sessions. Targeted at ketamine clinics and practitioners.

3Music for Breathwork
CategoryTherapeutic Music Software
Description

Adaptive music platform for breathwork practitioners, featuring real-time adaptability to session rhythm and remote session capabilities via sharable music links. Targeted at body-mind practitioners including breathwork facilitators and yoga teachers.

4Music for Psychotherapy
CategoryTherapeutic Music Software
Description

Person-centred music solution designed to support psychotherapists and mental health practitioners in integrating music into their therapeutic practice. Targeted at general psychotherapists, psychiatrists, and counselors.

5For Researchers
CategoryResearch Platform Access
Description

Access to the Wavepaths music platform and research support for clinical trials involving MDMA, psilocybin, DMT and other psychedelic medicines. Targeted at university and clinical research institutions.

6Deep Listening
CategoryFacilitated Listening Service
Description

Paid transformative music listening method providing guided, introspective experiences that foster meaning-making and emotional insight, facilitated over Zoom by Dr. Mendel Kaelen. Sessions last 1-3 hours and combine live-guided music experiences with post-session integration. Targeted at individuals and groups seeking introspective experiences.

7Foundations of Therapeutic Music
CategoryEducation and Training Program
Description

14-week experiential training and mentorship program teaching therapeutic musicality, situational flexibility, and multidisciplinary integration. Available in self-paced Essentials (€350) and live interactive Expert (€1,300) formats. Includes live sessions, playlist design workshops, and a Wavepaths subscription. Targeted at practitioners seeking to integrate music into therapeutic practice.

81:1 & Group Consultation
CategoryConsulting Services
Description

Individual and group consulting services with Dr. Mendel Kaelen drawing on 15+ years of therapeutic music research and application. Available for groups up to 6, up to 12, or 12+ people. Targeted at practitioners and organisations seeking personalised guidance on therapeutic music integration.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-01-01
Description

Academic research partnership supporting clinical trials with psychedelic medicines. One of several research institution partnerships.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-01-01
Description

Academic research partnership supporting clinical trials. Wavepaths is supporting ongoing research into psychedelic therapy at this institution.

3Monash University
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-01-01
Description

Academic research partnership supporting clinical trials. Wavepaths is supporting ongoing research into psychedelic therapy at this institution.

wavepaths.com
4Brian Eno
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2020-01-01
Description

Collaboration on popup research space in 2020. Eno participated in the validation of core hypotheses through a popup experiential space in Brick Lane, London.

wavepaths.com
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2019-01-01
Description

Early contributor and collaborator since 2019. Hopkins is one of the first contributors to Wavepaths, bringing visionary creative input on music and consciousness.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2011-01-01
Description

Research partnership where founder Mendel Kaelen conducted neuroscientific and clinical research on psychedelic therapy. Wavepaths was founded upon research demonstrating music's central role in psychedelic therapy conducted at Imperial College.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Non-profit organization shown in partnership logos on Wavepaths website, supporting psychedelic therapy practitioners.

8London Contemporary Orchestra
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Music collaboration relationship; Galya Bisengalieva, leader of the London Contemporary Orchestra, collaborates with Wavepaths as an artist.

wavepaths.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Calm
TypeBroad incumbent
Description

Large-scale mental wellness platform with Sleep Stories, music and meditations. Overlaps in wellness/mindfulness audio but operates as a mass-market consumer app without clinical personalization or therapeutic research backing.

TypeBroad incumbent
Description

Major mental health and meditation platform offering audio content including music and soundscapes. Comparable in mental wellness audio, but a broader incumbent without specialist therapeutic-music research focus.

TypeDirect peer
Description

AI-driven personalized soundscapes for focus, sleep and relaxation. Closely comparable technology (real-time adaptive generative audio) and overlapping wellness/mental health end use, though Endel targets consumers rather than clinical practitioners.

TypeDirect peer
Description

AI-composed functional music engineered to influence cognitive states (focus, sleep, meditation). Directly comparable adaptive-music technology and therapeutic/wellness positioning, with similar research-led differentiation strategy.

TypeDirect peer
Description

Generative AI music platform producing real-time, royalty-cleared audio streams for apps, creators and brands. Comparable core technology (real-time generative music) with overlapping content-licensing business model, though Wavepaths targets therapeutic rather than commercial use cases.

TypeEmerging player
Description

AI music composition platform creating emotional soundtrack-style music. Shares the AI music generation technology stack but focuses on content creation for media rather than live therapeutic adaptation.

7LUCID
TypeEmerging player
Description

Wellness audio app producing immersive soundscapes for sleep and relaxation. Comparable wellness/mindfulness audio product, though lacking Wavepaths' clinical validation and live adaptation.

TypeEmerging player
Description

Producer of brainwave entrainment and therapeutic audio tracks for meditation, sleep and consciousness exploration. Adjacent therapeutic audio niche with similar end-user intent but static rather than adaptive delivery.

TypeOthers
Description

Canadian non-profit advancing legal access to psilocybin-assisted therapy. Listed as a Wavepaths partner; serves the same psychedelic therapy ecosystem from an advocacy rather than technology angle.

TypeOthers
Description

Clinical-stage psychedelic therapy company running psilocybin trials for treatment-resistant depression. Not a music peer but a leading buyer/sponsor of therapeutic music infrastructure within psychedelic clinical research.

Market position
Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability1 record

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors9 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

wavepaths

Therapeutic Music Softwarewavepaths.com

Wavepaths is a London-based, fully remote company that develops an AI-driven adaptive music platform for psychedelic therapy, ketamine treatment, breathwork, and psychotherapy, serving 5,000+ practitioners across 29 countries and supporting 50,000+ clinical sessions.

What wavepaths does

Wavepaths is a London-headquartered, fully remote company that develops an AI-driven adaptive music generation platform designed to support therapist-led experiences across psychedelic therapy, ketamine infusion therapy, breathwork, and general psychotherapy. The platform generates personalised, real-time music by weaving together exclusive contributions from over 30 collaborating artists (including Jon Hopkins, Brian Eno, and Robert Rich), with in-session adaptation tuned to the individual, the therapeutic context, and the medicine being used. The company was founded in 2019 by Dr. Mendel Kaelen, a neuroscientist whose PhD research at Imperial College London first demonstrated music's central role in psychedelic therapy outcomes, and co-founder Anna Rickman.

The product surface comprises specialised offerings for each therapeutic modality — Music for Psychedelic Therapy, Music for Ketamine Infusion Therapy (covering both KAP and KIT), Music for Breathwork, and Music for Psychotherapy — plus a research tier supporting clinical trials at Imperial College London, McGill University, University of Washington, and Monash University. Supporting services include the Foundations of Therapeutic Music training course (€350 self-paced / €1,300 live), 1:1 and group consulting with Dr. Kaelen, and Deep Listening sessions facilitated over Zoom.

Wavepaths operates a primarily subscription-based revenue model (monthly practitioner access with 14-day free trials and category-specific discounts), complemented by fee-based training, consulting, and facilitated listening services. GTM is community-led and self-serve, amplified by free webinars, founder-led AMAs, and academic research partnerships. The platform is used by 5,000+ practitioners across 29 countries and has supported 50,000+ clinical sessions; the company raised $4.5M in seed funding in November 2021 from a consortium of psychedelic- and science-focused investors.

wavepaths firmographics

Firmographics
Name
wavepaths
Legal name
Wavepaths
Website
https://wavepaths.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
1–10 employees
Short description
Wavepaths is a London-based, fully remote company that develops an AI-driven adaptive music platform for psychedelic therapy, ketamine treatment, breathwork, and psychotherapy, serving 5,000+ practitioners across 29 countries and supporting 50,000+ clinical sessions.
Ownership category
akta.pro rank

wavepaths industry classification

Industry
Product category
Therapeutic Music Software
NAICS
Other Sound Recording Industries (512290), Sound Recording Industries (5122)
SIC
Services-Computer Programming, Data Processing, Etc. (7370)
akta.pro industry
PRIMARYMPAIAIAC
Mobile Music Creation Apps (Beatmaking, Songwriting, Practice)
Media, Entertainment & Sports/Music & Audio (Recording, Publishing, Streaming)/Music Technology & Software (DAWs, Plugins, Music Apps)
SECONDARYHSADAJAD
Sound Meditation & Sound Bath Sessions

Keywords

  • Adaptive therapeutic music
  • Psychedelic therapy platform
  • Ketamine infusion music
  • Breathwork music software
  • Music-assisted psychotherapy

Where wavepaths is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

wavepaths business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. Subscription Platform Access: Monthly subscription model for care providers to access the Wavepaths music platform for therapeutic sessions. Includes free trial periods and discounts for certain practitioner categories.
  2. Music Licensing for Breathwork: $25 per month licensing fee during beta phase for breathwork practitioners to use adaptive music.
  3. Educational Training Programs: Fee-based training courses including the Foundations of Therapeutic Music program (€350 for self-paced, €1,300 for live interactive), and 1:1/group consulting sessions with founder Mendel Kaelen.
  4. Deep Listening Sessions: Paid deep listening sessions facilitated over Zoom, offered individually or for groups, lasting 1-3 hours.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyBreathwork music licensing - beta pricing
SubscriptionPay-as-you-goFoundations of Therapeutic Music - Essentials (Self-Paced)
SubscriptionPay-as-you-goFoundations of Therapeutic Music - Expert (Live Interactive)
FreemiumPay-as-you-goPlatform Free Trial

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

wavepaths product offering

Product offering

Core offering

Wavepaths provides an AI-driven, person-centred adaptive music platform used by therapists, ketamine clinics, breathwork facilitators, and researchers during therapeutic sessions. The platform weaves exclusive musical contributions from over 30 world-renowned artists together in real time, adapting to the individual patient, the therapeutic context, and the medicine involved. Supporting offerings include an educational Foundations of Therapeutic Music training course, 1:1/group consulting, and facilitated Deep Listening sessions.

Product overview

Wavepaths is a music-as-medicine platform offering adaptive, person-centred therapeutic music solutions. The core platform includes multiple specialized applications: Music for Psychedelic Therapy, Music for Ketamine Infusion Therapy, Music for Breathwork, and Music for Psychotherapy. Supporting offerings include Deep Listening sessions (guided introspective music experiences), research support for clinical trials, and subscription access for care providers. Wavepaths' technology weaves musical contributions from over 30 collaborating artists together in real-time, adapting to each individual and therapeutic context. The platform is complemented by educational programs including a Foundations of Therapeutic Music training course and 1:1 consulting services. The company serves practitioners across 29 countries and supports over 50,000 clinical sessions.

Differentiator

Problem solved

Functional benefit

Products and services

  • Music for Psychedelic Therapy Adaptive, person-centred music platform designed to optimize therapeutic outcomes during psychedelic-assisted therapy sessions (psilocybin, MDMA, DMT) by customising music to the pharmacodynamics of the medicine and individual patient traits. Targeted at therapists, guides, and clinicians.
  • Music for Ketamine Infusion Therapy Therapeutic music solution for ketamine-assisted psychotherapy (KAP) and ketamine IV therapy (KIT) practitioners, supporting both infusion-only practices and psychotherapy sessions. Targeted at ketamine clinics and practitioners.
  • Music for Breathwork Adaptive music platform for breathwork practitioners, featuring real-time adaptability to session rhythm and remote session capabilities via sharable music links. Targeted at body-mind practitioners including breathwork facilitators and yoga teachers.
  • Music for Psychotherapy Person-centred music solution designed to support psychotherapists and mental health practitioners in integrating music into their therapeutic practice. Targeted at general psychotherapists, psychiatrists, and counselors.
  • For Researchers Access to the Wavepaths music platform and research support for clinical trials involving MDMA, psilocybin, DMT and other psychedelic medicines. Targeted at university and clinical research institutions.
  • Deep Listening Paid transformative music listening method providing guided, introspective experiences that foster meaning-making and emotional insight, facilitated over Zoom by Dr. Mendel Kaelen. Sessions last 1-3 hours and combine live-guided music experiences with post-session integration. Targeted at individuals and groups seeking introspective experiences.
  • Foundations of Therapeutic Music 14-week experiential training and mentorship program teaching therapeutic musicality, situational flexibility, and multidisciplinary integration. Available in self-paced Essentials (€350) and live interactive Expert (€1,300) formats. Includes live sessions, playlist design workshops, and a Wavepaths subscription. Targeted at practitioners seeking to integrate music into therapeutic practice.
  • 1:1 & Group Consultation Individual and group consulting services with Dr. Mendel Kaelen drawing on 15+ years of therapeutic music research and application. Available for groups up to 6, up to 12, or 12+ people. Targeted at practitioners and organisations seeking personalised guidance on therapeutic music integration.

Quantifiable outcome

  • All three positive therapeutic outcomes (mystical experience, autobiographical insight, depression reduction) were more likely when patients responded positively to music in psychedelic therapy studies
  • +1 more outcomes

Companies that use wavepaths

Customer profile

Named customers4 records

Segments5 records

Ideal customer profiles5 records

wavepaths technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature3 records

wavepaths partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core, major and minor.

  • McGill UniversitycoreStrategic or Co-development Partner · 1 January 2022Academic research partnership supporting clinical trials with psychedelic medicines. One of several research institution partnerships.
  • University of WashingtoncoreStrategic or Co-development Partner · 1 January 2022Academic research partnership supporting clinical trials. Wavepaths is supporting ongoing research into psychedelic therapy at this institution.
  • Monash UniversitycoreStrategic or Co-development Partner · 1 January 2022Academic research partnership supporting clinical trials. Wavepaths is supporting ongoing research into psychedelic therapy at this institution.
  • Brian EnomajorStrategic or Co-development Partner · 1 January 2020Collaboration on popup research space in 2020. Eno participated in the validation of core hypotheses through a popup experiential space in Brick Lane, London.
  • Jon HopkinsmajorStrategic or Co-development Partner · 1 January 2019Early contributor and collaborator since 2019. Hopkins is one of the first contributors to Wavepaths, bringing visionary creative input on music and consciousness.
  • Imperial College LondoncoreStrategic or Co-development Partner · 1 January 2011Research partnership where founder Mendel Kaelen conducted neuroscientific and clinical research on psychedelic therapy. Wavepaths was founded upon research demonstrating music's central role in psychedelic therapy conducted at Imperial College.
  • TheraPsilminorStrategic or Co-development PartnerNon-profit organization shown in partnership logos on Wavepaths website, supporting psychedelic therapy practitioners.
  • London Contemporary OrchestraminorStrategic or Co-development PartnerMusic collaboration relationship; Galya Bisengalieva, leader of the London Contemporary Orchestra, collaborates with Wavepaths as an artist.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

wavepaths competitors and assessment

Company assessment

Broad incumbents

  • Calm: Large-scale mental wellness platform with Sleep Stories, music and meditations. Overlaps in wellness/mindfulness audio but operates as a mass-market consumer app without clinical personalization or therapeutic research backing.
  • Headspace: Major mental health and meditation platform offering audio content including music and soundscapes. Comparable in mental wellness audio, but a broader incumbent without specialist therapeutic-music research focus.

Direct peers

  • Endel: AI-driven personalized soundscapes for focus, sleep and relaxation. Closely comparable technology (real-time adaptive generative audio) and overlapping wellness/mental health end use, though Endel targets consumers rather than clinical practitioners.
  • Brain.fm: AI-composed functional music engineered to influence cognitive states (focus, sleep, meditation). Directly comparable adaptive-music technology and therapeutic/wellness positioning, with similar research-led differentiation strategy.
  • Mubert: Generative AI music platform producing real-time, royalty-cleared audio streams for apps, creators and brands. Comparable core technology (real-time generative music) with overlapping content-licensing business model, though Wavepaths targets therapeutic rather than commercial use cases.

Emerging players

  • Aiva: AI music composition platform creating emotional soundtrack-style music. Shares the AI music generation technology stack but focuses on content creation for media rather than live therapeutic adaptation.
  • LUCID: Wellness audio app producing immersive soundscapes for sleep and relaxation. Comparable wellness/mindfulness audio product, though lacking Wavepaths' clinical validation and live adaptation.
  • iAwake Technologies: Producer of brainwave entrainment and therapeutic audio tracks for meditation, sleep and consciousness exploration. Adjacent therapeutic audio niche with similar end-user intent but static rather than adaptive delivery.

Others

  • TheraPsil: Canadian non-profit advancing legal access to psilocybin-assisted therapy. Listed as a Wavepaths partner; serves the same psychedelic therapy ecosystem from an advocacy rather than technology angle.
  • Compass Pathways: Clinical-stage psychedelic therapy company running psilocybin trials for treatment-resistant depression. Not a music peer but a leading buyer/sponsor of therapeutic music infrastructure within psychedelic clinical research.

Market position

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

wavepaths social profiles

Digital presence

wavepaths financial estimates

Financial estimate

Revenue estimate

Valuation estimate

wavepaths leadership team

Management profile

Number of profiles

Profiles7 records

wavepaths funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

wavepaths M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about wavepaths

What does wavepaths do?

Wavepaths provides an AI-driven, person-centred adaptive music platform used by therapists, ketamine clinics, breathwork facilitators, and researchers during therapeutic sessions. The platform weaves exclusive musical contributions from over 30 world-renowned artists together in real time, adapting to the individual patient, the therapeutic context, and the medicine involved. Supporting offerings include an educational Foundations of Therapeutic Music training course, 1:1/group consulting, and facilitated Deep Listening sessions.

Is wavepaths a public or private company?

wavepaths is a private company. It is classified as venture growth investor backed and is currently operating.

When was wavepaths founded?

wavepaths was founded in 2019. It employs 1 to 10 people.

Where is wavepaths based?

wavepaths is headquartered in London, United Kingdom, in the Europe region.

How does wavepaths make money?

Four revenue lines are on record. Subscription Platform Access are the primary driver. The others are music Licensing for Breathwork, educational Training Programs and deep Listening Sessions.

Who are wavepaths's main competitors?

Broad incumbents on record are Calm and Headspace. Direct peers are Endel, Brain.fm and Mubert. Emerging players are Aiva, LUCID and iAwake Technologies. Others are TheraPsil and Compass Pathways.

Does wavepaths have an API?

No public API is recorded for wavepaths.

What industry is wavepaths in?

wavepaths's product category is Therapeutic Music Software. Its primary akta.pro industry code is MPAIAIAC, Mobile Music Creation Apps (Beatmaking, Songwriting, Practice), with a secondary code of HSADAJAD, Sound Meditation & Sound Bath Sessions. Its NAICS code is 512290 and its SIC code is 7370.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireField Trip Announces Relaunch and Refresh of Its Award-Winning Psychedelic AppField Trip Health & Wellness announced a relaunch of its psychedelic guidance app, now available on App Store and Google Play. The app, downloaded over 80,000 times, includes offline music, higher bit-rate streaming, and exclusive Wavepaths tracks. The company plans new therapeutic programs and an accelerated app development program.WsjInvestors See Far Out Profits in Psychedelic MedicineEmpath Ventures, a psychedelic medicine VC firm, raised $2.1 million of a $10 million target for its first fund. The firm is backing companies like Mindstate Design Labs and Wavepaths, with investors betting on FDA approval of MDMA-assisted therapy in 2023.FinSMEsWavepaths Raises $4.5M in Seed FundingWavepaths, a London-based digital platform for psychedelic therapy music, secured $4.5 million in seed funding from investors including Heron Rock and Reflex Capital. The capital will be used to develop the company's AI-driven music-generation algorithms and scale its platform for healthcare practices. Currently in closed beta with over 5,000 practitioners on the waiting list, Wavepaths plans a public release later this year.Ow.ly Link ShortenerMusic for psychedelic therapy provider Wavepaths raises $4.5M [VIDEO]Wavepaths, a startup providing music for psychedelic therapy, has secured $4.5 million in seed funding from investors including Heron Rock and Reflex Capital. The company utilizes adaptive music technology to support therapeutic outcomes for treatments involving ketamine, psilocybin, and MDMA. The raised capital will be used to develop personalization algorithms and scale the platform for healthcare providers.UktechnewsWavepaths secures £3.29 million Seed investment from investors including Heron RockWavepaths has secured $4.5 million in seed funding led by Heron Rock to develop its AI-powered music generation algorithms for psychedelic therapy. The investment will support scaling the platform and enhancing functionality for healthcare practitioners using treatments such as ketamine, psilocybin, and MDMA. The company is currently in closed beta with plans for a public release later this year.HypebotMusic for psychedelic therapy provider Wavepaths raises $4.5M [VIDEO]Wavepaths, a startup focused on integrating music into psychedelic therapy, raised $4.5 million in seed funding. The funding will be used to advance its music personalization algorithms and expand its platform for healthcare providers. The interest stems from growing clinical inquiry and research highlighting music's role in therapeutic outcomes.PrwebWavepaths Raises $4.5 Million to Expand Experiential Music Platform for Psychedelic TherapyWavepaths, a London-based provider of adaptive music for psychedelic therapy, announced on November 2, 2021 that it raised $4.5 million in its initial seed round from investors including Heron Rock, Reflex Capital, Bridge Builders Collaborative, Palo Santo and Empath Ventures. The funds will develop its personalization and music-generation algorithms, scale the platform and expand functionality for healthcare practices. The app is in closed beta, with public release expected later this year.WavepathsWavepaths Raises $4.5 Million to Expand Experiential Music Platform for Psychedelic TherapyWavepaths, a producer of music for psychedelic therapy, announced the successful raising of $4.5 million in its initial seed investment round to further develop its platform and algorithms. The funding will support the expansion of the company's AI-powered generative music system, which is designed to optimize therapeutic outcomes for clients undergoing treatments such as ketamine, psilocybin, and MDMA therapy. With the platform currently used in over 29 countries and a public release expected later this year, Wavepaths aims to enhance personalized care for mental health practitioners.